The Valley Desk

ArticleCancer discoveryPublished

Targeted MDM2 Degradation Reveals a New Vulnerability for p53-Inactivated Triple-Negative Breast Cancer

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Thomas Jefferson University, The Wistar Institute. Affiliation source

Publication record

Type
Article
Venue
Cancer discovery
Published
Subject terms
Cell Line, Tumor; Animals; Humans; Mice; Antineoplastic Agents; Survival Analysis; Apoptosis; Up-Regulation; Female; Tumor Suppressor Protein p53; Proto-Oncogene Proteins c-mdm2; Proteolysis
PubMed ID
36734633
PubMed Central ID
PMC10164114
Added to directory
Source checked

Report a correction or request removal